Showing 8671-8680 of 18131 results for "".
- Literature Review Examines Need for Better Treatment of PsO in Skin of Colorhttps://reachmd.com/news/Literature-Review-Examines-Need-Better-Treatment-PsO-Skin-Color/2471097/A recent literature review on psoriasis in patients with skin of color (SOC) “invokes an important call to action by the [International Psoriasis Council],” its authors wrote I the International Journal of Dermatology. “Education on diagnosing and treating psoriasis in all populations, inc
- Stereotactic Radiosurgery Proves Effective for Early-Stage Vestibular Schwannomashttps://reachmd.com/news/stereotactic-radiosurgery-proves-effective-for-early-stage-vestibular-schwannomas/2468573/For patients with Koos grade I vestibular schwannomas, stereotactic radiosurgery (SRS) provides a reliable option for tumor control, outperforming the "watch and wait" approach by a significant margin. A recent international study, known as the VISAS-K1 study, sheds light on the benefits of early
- Rise in Patients Seeking Botox to Cure ‘Tech Neck’ Caused by Time Hunching Over Deviceshttps://reachmd.com/news/rise-in-patients-seeking-botox-to-cure-tech-neck-caused-by-time-hunching-over-devices/2468235/Dr Soni said: “Some people are after a quick fix. But I only give one or two jabs and then recommend they see a physiotherapist, or take up yoga or Pilates, to improve their mobility and posture.”Dr Rowland Payne and Zoe Barley, a medical student
- World-First Lung Cancer Vaccine Trials Launched Across 7 Countrieshttps://reachmd.com/news/world-first-lung-cancer-vaccine-trials-launched-across-7-countries/2467940/Doctors have begun trialling the world’s first mRNA lung cancer vaccine in patients, as experts hailed its “groundbreaking” potential to save thousands of lives.Lung cancer is the world’s leading cause of cancer death, accounting for about 1.8m deaths every year. Survival rates i
- ‘Heart-in-a-Box’ Better Than Cooler for Heart Transplantshttps://reachmd.com/news/heart-in-a-box-better-than-cooler-for-heart-transplants/2467864/The established way of storing donated hearts before transplantation is to keep them at four degrees in potassium solution in a cooler with ice. Handling is a race against time, where matching, transportation and surgery need to happen within four hours to avoid i
- Managing Screen Time Without Banning Technologyhttps://reachmd.com/news/managing-screen-time-without-banning-technology/2467823/During the pandemic Jan Plass learned firsthand how nuanced the discussion around kids and screen time has to be. At one point, he became upset with his teenage children about how much time they were spending in front of screens.“So I go into their rooms ready to tell the
- ‘Symptom Triggered’ Test Can Pick Up Early-Stage Aggressive Ovarian Cancer in 1 in 4 of Affectedhttps://reachmd.com/news/symptom-triggered-test-can-pick-up-early-stage-aggressive-ovarian-cancer-in-1-in-4-of-affected/2467803/Symptom triggered testing, prompted by symptoms such as pain, abdominal bloating/swelling, and feeling full soon after starting to eat, can pick up early-stage aggressive ovarian cancer in 1 in 4 of those affected, according to new research. A study published in the I
- Disparities in Post-Stroke Care Detailed in New Studyhttps://reachmd.com/news/disparities-in-post-stroke-care-detailed-in-new-study/2467448/Hispanic people and people without private insurance who have experienced a stroke are more likely to be discharged to their home rather than to a health care facility, according to data published in Neurology Clinical Practice. The report provided additional insights i
- EHA 2024: Monoclonal Antibodies Continue to Dominate Multiple Myeloma Treatments - Pharmaceutical Technologyhttps://reachmd.com/news/eha-2024-monoclonal-antibodies-continue-to-dominate-multiple-myeloma-treatments-pharmaceutical-technology/2467321/Many significant Phase I-III studies targeting haematological malignancies, such as multiple myeloma (MM), were presented at the European Hematology Association Hybrid Congress 2024 (EHA 2024), which took place from 13 – 16 June. MM is the third
- EHA 2024: Monoclonal Antibodies Continue to Dominate Multiple Myeloma Treatmentshttps://reachmd.com/news/eha-2024-monoclonal-antibodies-continue-to-dominate-multiple-myeloma-treatments/2467248/Many significant Phase I-III studies targeting haematological malignancies, such as multiple myeloma (MM), were presented at the European Hematology Association Hybrid Congress 2024 (EHA 2024), which took place from 13 – 16 June. MM is the third most prevalent blood cancer w